{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":337686,"items":[{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:53:10Z","timestamp":1791881590847,"version":"4.3.4"},"description":"Drug","reference-count":0,"publisher":"Royal Pharmaceutical Society","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.18578\/bnfc.791549275","type":"component","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T09:00:08Z","timestamp":1447405208000},"source":"Crossref","is-referenced-by-count":0,"title":["sumatriptan"],"prefix":"10.18578","member":"162","deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:27:53Z","timestamp":1791880073000},"score":19.19733,"resource":{"primary":{"URL":"https:\/\/www.medicinescomplete.com\/#\/content\/bnfc\/_791549275"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18578\/bnfc.791549275","relation":{"is-component-of":[{"id-type":"doi","id":"10.18578\/BNFC.680335055","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T22:11:32Z","timestamp":1655071892954},"edition-number":"1","reference-count":5,"publisher":"Cambridge University Press","license":[{"start":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:00:00Z","timestamp":1349395200000},"content-version":"unspecified","delay-in-days":29,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2012,9,6]]},"DOI":"10.1017\/cbo9781139194464.096","type":"book-chapter","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T15:04:39Z","timestamp":1349535879000},"page":"439-441","source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan, Sumatriptan\/Naproxen"],"prefix":"10.1017","member":"56","reference":[{"key":"9781139194464.CBO9781139194464A102_CBO9781139194464bib597","doi-asserted-by":"crossref","unstructured":"Brandes JL Kudrow D Stark SR Sumatriptan-naproxen for acute treatment of migraine: a randomized trial JAMA 2007 297 1443","DOI":"10.1001\/jama.297.13.1443"},{"key":"9781139194464.CBO9781139194464A102_CBO9781139194464bib601","doi-asserted-by":"crossref","unstructured":"Wenzel RG Tepper S Korab WE Freitag F Serotonin syndrome risks when combining SSRI\/SNRI drugs and triptans: is the FDA's alert warranted? Ann Pharmacother 2008 42 1692","DOI":"10.1345\/aph.1L260"},{"key":"9781139194464.CBO9781139194464A102_CBO9781139194464bib599","doi-asserted-by":"crossref","unstructured":"G\u00f6bel H Heinze A Stolze H Heinze-Kuhn K Lindner V Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment Cephalalgia 1999 19 676","DOI":"10.1046\/j.1468-2982.1999.019007676.x"},{"key":"9781139194464.CBO9781139194464A102_CBO9781139194464bib598","doi-asserted-by":"crossref","unstructured":"Ferrari MD Roon KI Lipton RB Goadsby PJ Oral triptans (serotonin 5-HT(1B\/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials Lancet 2001 358 1668","DOI":"10.1016\/S0140-6736(01)06711-3"},{"key":"9781139194464.CBO9781139194464A102_CBO9781139194464bib600","doi-asserted-by":"crossref","unstructured":"Scholpp J Schellenberg R Moeckesch B Banik N Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan Cephalalgia 2004 24 925","DOI":"10.1111\/j.1468-2982.2004.00802.x"}],"container-title":["Essential Pain Pharmacology"],"link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/04E8DD6934F07340438516D70DCEC83C","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T21:44:39Z","timestamp":1655070279000},"score":19.122639,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/CBO9781139194464A102\/type\/book_part"}},"issued":{"date-parts":[[2012,9,6]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1017\/cbo9781139194464.096","published":{"date-parts":[[2012,9,6]]}},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:53:59Z","timestamp":1791881639722,"version":"4.3.4"},"description":"Drug","reference-count":0,"publisher":"Royal Pharmaceutical Society","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.18578\/bnf.791549275","type":"component","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T08:47:16Z","timestamp":1447404436000},"source":"Crossref","is-referenced-by-count":0,"title":["sumatriptan"],"prefix":"10.18578","member":"162","deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:29:26Z","timestamp":1791880166000},"score":19.039753,"resource":{"primary":{"URL":"https:\/\/www.medicinescomplete.com\/#\/content\/bnf\/_791549275"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18578\/bnf.791549275","relation":{"is-component-of":[{"id-type":"doi","id":"10.18578\/BNF.147942626","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:00:46Z","timestamp":1783065646768,"version":"3.54.6"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80102_03_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":1,"title":["Sumatriptan"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:50:24Z","timestamp":1629129024000},"score":19.037624,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80102_03_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80102_03_01"},{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:04:33Z","timestamp":1781107473307,"version":"3.54.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80102_03_03","type":"standard","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:47:16Z","timestamp":1781106436000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:48:47Z","timestamp":1781106527000},"score":18.952358,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80102_03_03.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80102_03_03"},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T07:57:50Z","timestamp":1649145470373},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80106_03_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan Injection"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:52:59Z","timestamp":1629125579000},"score":18.493624,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80106_03_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80106_03_01"},{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:06:45Z","timestamp":1781107605621,"version":"3.54.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80108_02_03","type":"standard","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:47:16Z","timestamp":1781106436000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan, Comprim\u00e9s"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:48:00Z","timestamp":1781106480000},"score":18.404257,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80108_02_03.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80108_02_03"},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:38:09Z","timestamp":1648906689608},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80108_02_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:51Z","timestamp":1629123531000},"score":18.368904,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80108_02_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80108_02_01"},{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:03:32Z","timestamp":1781107412410,"version":"3.54.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80106_03_03","type":"standard","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:47:16Z","timestamp":1781106436000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan, Solution Injectable"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:48:52Z","timestamp":1781106532000},"score":18.296843,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80106_03_03.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80106_03_03"},{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:03:56Z","timestamp":1781107436652,"version":"3.54.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80107_07_03","type":"standard","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:47:16Z","timestamp":1781106436000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan, Spray Nasal"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:48:28Z","timestamp":1781106508000},"score":18.27558,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80107_07_03.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80107_07_03"},{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:00:41Z","timestamp":1783065641344,"version":"3.54.6"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80104_05_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":1,"title":["Sumatriptan Succinate"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:27:16Z","timestamp":1629127636000},"score":18.091497,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80104_05_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80104_05_01"},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T17:04:21Z","timestamp":1648919061817},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m1402_01_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan Compounded Oral Suspension"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:49:02Z","timestamp":1629128942000},"score":18.085854,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M1402_01_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m1402_01_01"},{"indexed":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:09:04Z","timestamp":1700525344087},"reference-count":0,"publisher":"CSIR-National Institute of Science Communication and Policy Research (NIScPR)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJC"],"DOI":"10.56042\/ijc.v62i11.5015","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:39:08Z","timestamp":1700458748000},"source":"Crossref","is-referenced-by-count":0,"title":["A Highly Efficient Route for Synthesis of N-Hydroxymethyl Sumatriptan and Sumatriptan Dimer; Impurity C and H of Anti-migraine drug Sumatriptan"],"prefix":"10.56042","volume":"62","member":"31608","published-online":{"date-parts":[[2023,11,17]]},"container-title":["Indian Journal of Chemistry"],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T05:39:20Z","timestamp":1700458760000},"score":18.050419,"resource":{"primary":{"URL":"https:\/\/or.niscpr.res.in\/index.php\/IJC\/article\/view\/5015"}},"issued":{"date-parts":[[2023,11,17]]},"references-count":0,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,17]]}},"URL":"https:\/\/doi.org\/10.56042\/ijc.v62i11.5015","ISSN":["0019-5103","2583-1321"],"issn-type":[{"value":"0019-5103","type":"print"},{"value":"2583-1321","type":"electronic"}],"published":{"date-parts":[[2023,11,17]]}},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:53:59Z","timestamp":1791881639728,"version":"4.3.4"},"description":"Drug","reference-count":0,"publisher":"Royal Pharmaceutical Society","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.18578\/bnf.985874895","type":"component","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T04:37:44Z","timestamp":1751949464000},"source":"Crossref","is-referenced-by-count":0,"title":["sumatriptan with naproxen"],"prefix":"10.18578","member":"162","deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:29:26Z","timestamp":1791880166000},"score":17.908863,"resource":{"primary":{"URL":"https:\/\/www.medicinescomplete.com\/#\/content\/bnf\/_985874895"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.18578\/bnf.985874895","relation":{"is-component-of":[{"id-type":"doi","id":"10.18578\/BNF.147942626","asserted-by":"object"}]}},{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:06:20Z","timestamp":1781107580296,"version":"3.54.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80104_05_03","type":"standard","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:47:16Z","timestamp":1781106436000},"source":"Crossref","is-referenced-by-count":0,"title":["Succinate de Sumatriptan"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:48:31Z","timestamp":1781106511000},"score":17.908863,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80104_05_03.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80104_05_03"},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T11:05:27Z","timestamp":1648897527498},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m80107_07_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan Nasal Spray"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:25:29Z","timestamp":1629127529000},"score":17.743647,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M80107_07_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m80107_07_01"},{"indexed":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T04:23:54Z","timestamp":1728361434148},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m3814_10201_01","type":"standard","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T18:47:18Z","timestamp":1728326838000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan and Naproxen Sodium Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T18:47:59Z","timestamp":1728326879000},"score":17.531733,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M3814_10201_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m3814_10201_01"},{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T12:07:26Z","timestamp":1715083646027},"publisher-location":"2215 Constitution Avenue, N.W. Washington, DC 20037-2985","reference-count":0,"publisher":"The American Pharmacists Association","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2017,1]]},"DOI":"10.21019\/pfdi.sumatriptan","type":"book-chapter","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:42:57Z","timestamp":1555508577000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan"],"prefix":"10.21019","member":"23","published-online":{"date-parts":[[2019,4,17]]},"container-title":["PharmacotherapyFirst Drug Information"],"language":"en","deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:44:15Z","timestamp":1555508655000},"score":17.428394,"resource":{"primary":{"URL":"https:\/\/pharmacylibrary.com\/doi\/10.21019\/pfdi.sumatriptan"}},"issued":{"date-parts":[[2017,1]]},"references-count":0,"alternative-id":["10.21019\/pfdi.sumatriptan","10.21019\/druginformation"],"URL":"https:\/\/doi.org\/10.21019\/pfdi.sumatriptan","published":{"date-parts":[[2017,1]]}},{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:03:20Z","timestamp":1789571000832,"version":"build-2803163510"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m3814_02_01","type":"standard","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:15:12Z","timestamp":1789568112000},"source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan and Naproxen Sodium Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:15:33Z","timestamp":1789568133000},"score":17.379185,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M3814_02_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m3814_02_01"},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T18:17:22Z","timestamp":1649182642658},"reference-count":1,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s40278-018-40570-z","type":"journal-article","created":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T11:13:59Z","timestamp":1515237239000},"page":"633-633","source":"Crossref","is-referenced-by-count":0,"title":["Sumatriptan"],"prefix":"10.1007","volume":"1683","member":"297","published-online":{"date-parts":[[2018,1,6]]},"reference":[{"key":"40570_CR1","doi-asserted-by":"crossref","unstructured":"Paszkowska M. Greater occipital nerve block mayaffect the effectiveness of triptan overuse headache treatment. Regional Anesthesia and Pain Medicine 42 (Suppl. 1): e189 abstr. ESRA7-0524, No. 5, Oct 2017. Available from: URL: http:\/\/doi.org\/10.1097\/AAP.0000000000000656 [abstract] - Poland","DOI":"10.1097\/AAP.0000000000000656"}],"container-title":["Reactions Weekly"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-018-40570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40278-018-40570-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40278-018-40570-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,6]],"date-time":"2018-01-06T12:43:57Z","timestamp":1515242637000},"score":17.27472,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40278-018-40570-z"}},"subtitle":["Headache due to over use of sumatriptan: case report"],"issued":{"date-parts":[[2018,1]]},"references-count":1,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["40570"],"URL":"https:\/\/doi.org\/10.1007\/s40278-018-40570-z","ISSN":["0114-9954","1179-2051"],"issn-type":[{"value":"0114-9954","type":"print"},{"value":"1179-2051","type":"electronic"}],"published":{"date-parts":[[2018,1]]}}],"items-per-page":20,"query":{"start-index":0,"search-terms":null}}}